NASDAQ:VACH Voyager Acquisition (VACH) Stock Price, News & Analysis $10.31 +0.00 (+0.00%) As of 05/30/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Voyager Acquisition Stock (NASDAQ:VACH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Voyager Acquisition alerts:Sign Up Key Stats Today's Range$10.31▼$10.3150-Day Range$10.17▼$10.3352-Week Range$9.95▼$11.20Volume25,018 shsAverage Volume124,447 shsMarket Capitalization$326.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVoyager Acquisition Corp. is a blank check company. It formed for the purpose of merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Voyager Acquisition Corp. is based in BROOKLYN, N.Y.Read More… Receive VACH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Voyager Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address VACH Stock News HeadlinesVERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology PlatformMay 29 at 6:34 PM | globenewswire.comVERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology PlatformMay 29 at 10:34 AM | globenewswire.comUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they wish they could live. But thanks to a little-known “loophole” in the markets after midnight...June 1, 2025 | Timothy Sykes (Ad)VERAXA Biotech Appoints Rick Austin as Chief Scientific OfficerMay 20, 2025 | globenewswire.comVoyager Acquisition Corp.: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 6, 2025 | finanznachrichten.deVERAXA Biotech GmbH: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 5, 2025 | finanznachrichten.deVeraxa to go public in $1.6bn SPAC deal with VoyagerApril 23, 2025 | msn.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comSee More Headlines VACH Stock Analysis - Frequently Asked Questions How have VACH shares performed this year? Voyager Acquisition's stock was trading at $10.02 at the start of the year. Since then, VACH shares have increased by 2.9% and is now trading at $10.3150. View the best growth stocks for 2025 here. Who are Voyager Acquisition's major shareholders? Voyager Acquisition's top institutional shareholders include AQR Arbitrage LLC (4.49%), Wolverine Asset Management LLC (4.46%), Westchester Capital Management LLC (3.99%) and Schechter Investment Advisors LLC (2.18%). How do I buy shares of Voyager Acquisition? Shares of VACH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/31/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry Holding & other investment offices Sub-IndustryTrading Current SymbolNASDAQ:VACH CIK2006815 WebN/A Phone347-720-2907FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares31,625,000Free FloatN/AMarket Cap$326.21 million OptionableN/A BetaN/A Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:VACH) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VACH Stock Free VACH Stock Alerts